Novo Nordisk Pharmatech and Novozymes enter into enzyme partnership

Novo Nordisk Pharmatech and Novozymes have partnered up to developed specialty enzymes meant for biopharma processing and regenerative medicines, the firms announce in a shared press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app